Skip to main content
MGPI logo

MGPI · Mgp Ingredients Inc

Track MGPI — free
$12.79 -0.09 (-0.70%) At close · Oct 2
Market Cap
$273.98M
Shares
21.37M
Volume · Oct 2 194.22K Avg daily vol (3M) 219.23K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$12.79 Open$12.96 Day$12.75–13.14 52W close$12.74–26.40 Avg vol 30d262K Short int1.0M · 4.7% float · 4.0d Short vol64% Last earningsJul 29, 2026 DataJan 2020–Oct 2026 Filing10-Q · Jul 29

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 3 wks
filed Jul 29, 2026
call held Jul 29, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$521.15M
Trailing 12 months
Net income (TTM)
−$239.59M
Trailing 12 months
Revenue growth YoY
-12.5%
Year over year
Operating margin
-51.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
19.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.2%
Year over year · more shares
Price change (1Y)
-48.2%
Trailing year
Short interest
4.7%
Latest settlement · 4.0 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jul 29, 2026
Q2 FY26

TL;DR. MGP Ingredients reaffirmed full-year 2026 guidance despite a 15% consolidated sales decline and a 23% drop in adjusted EBITDA, as Branded Spirits premium-plus growth (Penelope +13%, Yellowstone +54%) and gross margin expansion in Branded Spirits and Distilling Solutions were offset by continued brown goods weakness and a sharp Ingredient Solutions margin compression from elevated waste starch disposal costs.

Bullish
  • + Branded Spirits premium-plus portfolio grew 5% with Penelope up 13% and Yellowstone up 54%, outperforming Nielsen and NAPCA declines.
  • + Branded Spirits gross margin expanded 20 basis points to 53.0% on favorable portfolio mix and RGM efforts.
  • + Distilling Solutions gross margin improved ~110 bps to 38.7% on cost savings and favorable mix despite a 42% sales decline.
  • + Company reaffirmed full-year 2026 guidance: sales $480-$500M, adjusted EBITDA $90-$98M, adjusted basic EPS $1.50-$1.80.
Bearish
  • − Consolidated gross margin declined ~270 bps to 37.4% as Ingredient Solutions waste costs pressured profitability.
  • − Net debt leverage ratio jumped to 3.5x from 2.1x at end of March following the ~$111M Penelope earn-out payment.
  • − A $2.1M credit loss provision was taken in Q2 related to the RNDC Chapter 11 bankruptcy filing.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −33%
below
Price vs 50-day avg −21%
below
RSI (14) 28
oversold
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −22%
trailing
6-month return −34%
trailing
YTD return −47%
this year
Relative strength −46%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $16 › 200d $19 — 200d above 50d
Institutional flow Accumulating
1 of 152 funds reported for Sep 30 · net +5.5K sh shares
Insider flow Distributing
Net -$985.6K over 90 days · 100% sells
Short interest Falling
4.72% of float · ▼ -4.8% MoM · 4.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
152 holders — mid 3-yr range
Squeeze score 50
elevated · 0–100
Fundamentals
Fair
Revenue growth −14%
Y/Y
Gross margin 1008%
contracting
EPS growth −420%
Y/Y
Free cash flow $76.0M
Buyback $53.4M
remaining
Balance sheet $32.7M
net debt
Quant / Vol
risk profile
Very High
Volatility 43%
annualized · 1-yr
Max drawdown −52%
past year
ATR 4.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 4
Latest guidance · from the Earnings Call filed Jul 29, 2026
full-year 2026
Adjusted EBITDA Non-GAAP Initiated $90M – $98M
Effective tax rate Initiated 23%
Operating cash flow Initiated $50M – $55M
Branded Spirits A&P as a percentage of Branded Spirits sales Initiated 13% – 14%
2026
Net sales $480M – $500M
prior FY $536.38M midpoint −8.6% Y/Y
Net whiskey put away $13M – $18M
full year
CapEx $20M
Branded Spirits A&P 13% – 14%
Guided vs delivered · last 4 settled
Sales fiscal 2024
guided $742M – $756M
$703.63M Miss −6.1%
Sales fiscal 2023
guided $815M – $835M
$836.52M Beat +1.4%
Sales full year fiscal 2022
guided $690M – $715M
$782.36M Beat +11.4%
Sales fiscal 2021
guided $570M – $580M
$626.72M Beat +9.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−33% Bearish
Price vs 50-day avg
−21% Bearish
RSI (14)
28 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $16 › 200d $19 — 200d above 50d
Institutional flow Accumulating
1 of 152 funds reported for Sep 30 · net +5.5K sh shares
Insider flow Distributing
Net -$985.6K over 90 days · 100% sells
Short interest Falling
4.72% of float · ▼ -4.8% MoM · 4.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
152 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $13 Now $13 · 0% Range high $26
vs 200-day avg -33% vs 50-day avg -21%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Beverages - Wineries & Distilleries — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MGPI
Mgp Ingredients Inc
this stock
$273.98M -47.4% -13.5% — 4.7%
DEO
Diageo PLC
$47.31B -1.8% — — 0.6%
BF-B
Brown Forman Corp
$12.06B +0.4% -1.2% 17.0 7.1%
APHD
Verde Bio Holdings, Inc.
$2.59B +85.2% -100.0% — 0.0%
SNDL
SNDL Inc.
$344.57M -25.3% — — 0.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
152
% held
73.3%
Reported
1 of 152
Top holder
Integrated Wealth Concept…
Held Float
View
Held by Funds
Fund positions
168
View
Short & Settlement
Short Interest Falling
Shares short
1.0M
Days to cover
4.0d
Change
-51.1K sh
View
Short Volume
Short vol %
64%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
13.6K
Value
$205.5K
As of
Sep 10, 2026
View
Off-Exchange
Off-exchange %
47.5%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$985.6K
Buyers / Sellers
0 / 2
Buyers Sellers
View
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Oct 31, 2025
View
Financials
Financials
Revenue (FY)
$536.4M
Net income (FY)
$-107.8M
EPS diluted
$-4.99
View
Buybacks
Authorized
$100.0M
Remaining
$53.4M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 7, 2026
This year
12
View
Proposed Sales
Value
$896.4K
Shares
60.7K
Filed
Sep 15, 2026
View
Earnings & Events
Webcasts
Last webcast
Jul 29, 2026
View

Performance

5D 20D 120D MTD YTD
MGPI -0.2% -21.7% -33.8% -3.5% -47.4%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY 0.0% -21.3% -46.0% -4.4% -60.2%

Capital returns

Buyback program · as of Mar 31, 2026
Authorized
$100.00M
Spent (derived)
$46.59M
Remaining
$53.41M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 835011 CUSIP 55303J106 13F (30d) 4 filings 4 filers Visit website Investor relations